WO2002047607A3 - Process for the preparation of a fast dissolving dosage form - Google Patents
Process for the preparation of a fast dissolving dosage form Download PDFInfo
- Publication number
- WO2002047607A3 WO2002047607A3 PCT/IB2001/002354 IB0102354W WO0247607A3 WO 2002047607 A3 WO2002047607 A3 WO 2002047607A3 IB 0102354 W IB0102354 W IB 0102354W WO 0247607 A3 WO0247607 A3 WO 0247607A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- preparation
- dosage form
- fast dissolving
- dissolving dosage
- tablet
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Zoology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Preparation (AREA)
Abstract
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2002220968A AU2002220968A1 (en) | 2000-12-15 | 2001-12-07 | Process for the preparation of a fast dissolving dosage form |
EP01270300A EP1343481A4 (en) | 2000-12-15 | 2001-12-07 | Process for the preparation of a fast dissolving dosage form |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN1170/DEL/2000 | 2000-12-15 | ||
IN1170DE2000 IN192750B (en) | 2000-12-15 | 2000-12-15 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2002047607A2 WO2002047607A2 (en) | 2002-06-20 |
WO2002047607A3 true WO2002047607A3 (en) | 2003-03-20 |
Family
ID=11097139
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2001/002354 WO2002047607A2 (en) | 2000-12-15 | 2001-12-07 | Process for the preparation of a fast dissolving dosage form |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1343481A4 (en) |
AU (1) | AU2002220968A1 (en) |
IN (1) | IN192750B (en) |
WO (1) | WO2002047607A2 (en) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8858210B2 (en) | 2009-09-24 | 2014-10-14 | Mcneil-Ppc, Inc. | Manufacture of variable density dosage forms utilizing radiofrequency energy |
US8865204B2 (en) | 2009-09-24 | 2014-10-21 | Mcneil-Ppc, Inc. | Manufacture of lozenge product with radiofrequency |
US8968769B2 (en) | 2007-10-31 | 2015-03-03 | Mcneil-Ppc, Inc. | Orally disintegrative dosage form |
US9233491B2 (en) | 2012-05-01 | 2016-01-12 | Johnson & Johnson Consumer Inc. | Machine for production of solid dosage forms |
US9445971B2 (en) | 2012-05-01 | 2016-09-20 | Johnson & Johnson Consumer Inc. | Method of manufacturing solid dosage form |
US9511028B2 (en) | 2012-05-01 | 2016-12-06 | Johnson & Johnson Consumer Inc. | Orally disintegrating tablet |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10232113A1 (en) | 2002-07-16 | 2004-01-29 | Bayer Ag | Medicinal products containing vardenafil hydrochloride trihydrate |
KR100503949B1 (en) * | 2003-04-28 | 2005-07-26 | 주식회사유한양행 | A composition of fast dissolving tablets effectively masked bitter taste of ondansetron hydrochloride |
FR2858556B1 (en) * | 2003-08-06 | 2006-03-10 | Galenix Innovations | DISPERSIBLE AND / OR ORODISPERSIBLE SOLID PHARMACEUTICAL COMPOSITION, NOT PELLETIZED, CONTAINING AT LEAST THE METFORMIN ACTIVE INGREDIENT, AND PROCESS FOR PREPARING THE SAME |
EP1510208A1 (en) | 2003-08-22 | 2005-03-02 | Fournier Laboratories Ireland Limited | Pharmaceutical composition comprising a combination of metformin and statin |
WO2005062722A2 (en) * | 2003-11-21 | 2005-07-14 | Sun Pharmaceutical Industries Limited | Fexofenadine containing pharmaceutical formulation |
US20090060983A1 (en) * | 2007-08-30 | 2009-03-05 | Bunick Frank J | Method And Composition For Making An Orally Disintegrating Dosage Form |
EP2044929A1 (en) * | 2007-10-04 | 2009-04-08 | Laboratorios del Dr. Esteve S.A. | Oral fast distintegrating tablets |
DE102008047910A1 (en) | 2008-09-19 | 2010-03-25 | Molkerei Meggle Wasserburg Gmbh & Co. Kg | Tabletting excipient based on lactose and cellulose |
US8581001B2 (en) | 2010-04-16 | 2013-11-12 | Codman & Shurtleff | Metformin-cysteine prodrug |
US9119793B1 (en) | 2011-06-28 | 2015-09-01 | Medicis Pharmaceutical Corporation | Gastroretentive dosage forms for doxycycline |
CN102258497B (en) * | 2011-08-18 | 2013-01-09 | 海南良方医药有限公司 | Lamivudine tablet composition and preparation method thereof |
US10842802B2 (en) | 2013-03-15 | 2020-11-24 | Medicis Pharmaceutical Corporation | Controlled release pharmaceutical dosage forms |
CN103432091A (en) * | 2013-09-13 | 2013-12-11 | 钟术光 | Improved-performance tablet and preparation method thereof |
ES2750323T3 (en) | 2014-01-10 | 2020-03-25 | Johnson & Johnson Consumer Inc | Method for manufacturing a tablet using radio frequency and loss coated particles |
US10493026B2 (en) | 2017-03-20 | 2019-12-03 | Johnson & Johnson Consumer Inc. | Process for making tablet using radiofrequency and lossy coated particles |
HUE064287T2 (en) | 2019-02-22 | 2024-02-28 | Catalent Uk Swindon Zydis Ltd | Minimizing agglomeration of drug particle coating material during storage to stabilize disintegration times of pharmaceutical products |
US11166919B2 (en) | 2019-02-22 | 2021-11-09 | Catalent U.K. Swindon Zydis Limited | Minimizing agglomeration, aeration, and preserving the coating of pharmaceutical compositions comprising ibuprofen |
US11179331B1 (en) | 2020-04-21 | 2021-11-23 | Cure Pharmaceutcai Holding Corp | Oral soluble film containing sildenafil citrate |
CA3178769A1 (en) | 2020-05-18 | 2021-11-25 | Jonas Savmarker | New pharmaceutical composition for drug delivery |
AR127780A1 (en) | 2021-11-25 | 2024-02-28 | Orexo Ab | NEW PHARMACEUTICAL COMPOSITION THAT COMPRISES ADRENALINE |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4946684A (en) * | 1989-06-20 | 1990-08-07 | American Home Products Corporation | Fast dissolving dosage forms |
US5631023A (en) * | 1993-07-09 | 1997-05-20 | R.P. Scherer Corporation | Method for making freeze dried drug dosage forms |
US5866163A (en) * | 1993-09-10 | 1999-02-02 | Fuisz Technologies Ltd. | Process and apparatus for making rapidly dissolving dosage units and product therefrom |
US6083531A (en) * | 1996-04-16 | 2000-07-04 | Novartis Consumer Health S.A. | Fast disintegrating oral dosage form |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6115830A (en) * | 1984-06-28 | 1986-01-23 | ザ プロクタ− アンド ガンブル カンパニ− | Antacid composition and manufacture |
GB2293099A (en) * | 1994-09-15 | 1996-03-20 | Mailway Packaging Group Ltd | Drug formulation |
WO1999043306A1 (en) * | 1998-02-26 | 1999-09-02 | Banyu Pharmaceutical Co., Ltd. | An orally disintegrating composition and its manufacturing method |
GT199900061A (en) * | 1998-05-15 | 2000-10-14 | Pfizer | PHARMACEUTICAL FORMULATIONS. |
-
2000
- 2000-12-15 IN IN1170DE2000 patent/IN192750B/en unknown
-
2001
- 2001-12-07 EP EP01270300A patent/EP1343481A4/en not_active Withdrawn
- 2001-12-07 AU AU2002220968A patent/AU2002220968A1/en not_active Abandoned
- 2001-12-07 WO PCT/IB2001/002354 patent/WO2002047607A2/en not_active Application Discontinuation
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4946684A (en) * | 1989-06-20 | 1990-08-07 | American Home Products Corporation | Fast dissolving dosage forms |
US5631023A (en) * | 1993-07-09 | 1997-05-20 | R.P. Scherer Corporation | Method for making freeze dried drug dosage forms |
US5866163A (en) * | 1993-09-10 | 1999-02-02 | Fuisz Technologies Ltd. | Process and apparatus for making rapidly dissolving dosage units and product therefrom |
US6083531A (en) * | 1996-04-16 | 2000-07-04 | Novartis Consumer Health S.A. | Fast disintegrating oral dosage form |
Non-Patent Citations (1)
Title |
---|
See also references of EP1343481A4 * |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8968769B2 (en) | 2007-10-31 | 2015-03-03 | Mcneil-Ppc, Inc. | Orally disintegrative dosage form |
US8858210B2 (en) | 2009-09-24 | 2014-10-14 | Mcneil-Ppc, Inc. | Manufacture of variable density dosage forms utilizing radiofrequency energy |
US8865204B2 (en) | 2009-09-24 | 2014-10-21 | Mcneil-Ppc, Inc. | Manufacture of lozenge product with radiofrequency |
US8871263B2 (en) | 2009-09-24 | 2014-10-28 | Mcneil-Ppc, Inc. | Manufacture of tablet in a die utilizing radiofrequency energy and meltable binder |
US9233491B2 (en) | 2012-05-01 | 2016-01-12 | Johnson & Johnson Consumer Inc. | Machine for production of solid dosage forms |
US9445971B2 (en) | 2012-05-01 | 2016-09-20 | Johnson & Johnson Consumer Inc. | Method of manufacturing solid dosage form |
US9511028B2 (en) | 2012-05-01 | 2016-12-06 | Johnson & Johnson Consumer Inc. | Orally disintegrating tablet |
Also Published As
Publication number | Publication date |
---|---|
EP1343481A2 (en) | 2003-09-17 |
IN192750B (en) | 2004-05-15 |
WO2002047607A2 (en) | 2002-06-20 |
EP1343481A4 (en) | 2004-03-17 |
AU2002220968A1 (en) | 2002-06-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2002047607A3 (en) | Process for the preparation of a fast dissolving dosage form | |
WO2004069198A3 (en) | Sugar-free oral transmucosal solid dosage forms and uses thereof | |
MXPA02003596A (en) | Novel pharmaceutical compositions of anti-tubercular drugs and process for their preparation. | |
AU2002216701A1 (en) | Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs | |
WO2002094774A3 (en) | Oxcarbazepine dosage forms | |
UA63993C2 (en) | Pharmaceutical flash-melt oral dosage forms (variants) and method for their preparation | |
WO2001068092A3 (en) | Glycogen phosphorylase inhibitor | |
WO2007009806A3 (en) | Solid dosage formulations of narcotic drugs having improved buccal adsorption | |
PT1094788E (en) | DISSIMULATION OF FLAVOR WITH CROSCARMELOSE | |
WO2002045684A3 (en) | Rapidly dispersing pharmaceutical composition comprising effervescent agents | |
HUP0203540A2 (en) | Extended release formulations of erythromycin derivatives | |
WO2007031887A3 (en) | Extended release pharmaceutical composition of metformin and a process for producing it | |
GR20020100506A (en) | Cefuroxime axetil-based pharmaceutical composition | |
HK1067626A1 (en) | Novel 2h-pyridazine-3-one derivatives, pharmaceutical compositions containing the same and a process for the preparation of the active ingredient | |
WO2003034991A3 (en) | Taste masking spill-resistant formulation | |
WO2003075829A3 (en) | Tasteless directly compressible fast-dissolving complexes and pharmaceutical formulations thereof | |
MXPA04002714A (en) | Use of 2-oxo-1-pyrrolidine derivatives for the preparation of a drug. | |
EP1238662A3 (en) | Method for manufacturing drug granules, the drug granules and pharmaceutical preparation containing the drug granules | |
ZA200208761B (en) | Pharmaceutical form of administration for peptides, methods for its production and use. | |
HUP0202233A3 (en) | Derivatives and analogues of galanthamin, their use, pharmaceutical compositions containing them and process for the preparation of them | |
IL150528A0 (en) | Ibuprofen containing active agent preparation | |
AU2001238346A1 (en) | Modification of biopolymers for improved drug delivery | |
WO2002049607A3 (en) | Flavoured oral drug delivery system | |
MXPA03001752A (en) | Pharmaceutical formulation of salmeterol and fluticasone propionate. | |
WO2005009407A3 (en) | Oral pharmaceutical formulations of olanzapine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2001270300 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2001270300 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2001270300 Country of ref document: EP |